Metaceutic ApS: Financial statements 2025
CVR: 40638350
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Metaceutic ApS (CVR 40638350) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,095,622 and a net result of DKK 2,364,576 compared with DKK -1,318,986 the year before. Equity in the 2025 report amounted to DKK 276,791. The solvency ratio was 11.3%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,095,622
- Profit/Loss
- DKK 2,364,576
- Equity
- DKK 276,791
- Total Assets
- DKK 2,442,100
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.1 mio. | 2.4 mio. | 277 t. | 2 |
| 2024 | - | -48 t. | -1.3 mio. | -2.1 mio. | 1 |
| 2023 | - | -1.2 mio. | -2 mio. | -769 t. | 1 |
| 2022 | - | -987 t. | -1.8 mio. | 1.3 mio. | 2 |
| 2021 | - | -2.2 mio. | -4.2 mio. | 2.1 mio. | 4 |
Official annual report
How creditworthy is Metaceutic ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Metaceutic ApS has published its annual report for 2024. Gross profit came to DKK -48,469, and the net result was DKK -1,318,986.
About Metaceutic ApS
Metaceutic ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali Kazemi Seresht. The company is owned by Ginnerup Capital ApS and A. Kazemi ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,095,622 and a net result of DKK 2,364,576 compared with DKK -1,318,986 the year before. Equity in the 2025 report amounted to DKK 276,791.